Literature DB >> 20447630

BRCA carriers' thoughts on risk management in relation to preimplantation genetic diagnosis and childbearing: when too many choices are just as difficult as none.

Gwendolyn P Quinn1, Susan T Vadaparampil, Sharon Tollin, Cheryl A Miree, Devin Murphy, Bethanne Bower, Celso Silva.   

Abstract

Women with a BRCA mutation have unique concerns about childbearing and future fertility. In a focus group conducted among unaffected carriers, the majority of women held positive attitudes toward preimplantation genetic diagnosis to reduce transmission to future offspring and further identified unmet needs for education and support for decision making.
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20447630     DOI: 10.1016/j.fertnstert.2010.03.064

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  18 in total

1.  Preimplantation genetic diagnosis for inherited breast cancer: first clinical application and live birth in Spain.

Authors:  Teresa Ramón Y Cajal; Ana Polo; Olga Martínez; Carles Giménez; César Arjona; Gemma Llort; Lluís Bassas; Pere Viscasillas; Joaquin Calaf
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

2.  Performing and Declining PGD: Accounts of Jewish Israeli Women Who Carry a BRCA1/2 Mutation or Partners of Male Mutation Carriers.

Authors:  Efrat Dagan; Daphna Birenbaum-Carmeli; Eitan Friedman; Baruch Feldman
Journal:  J Genet Couns       Date:  2017-03-06       Impact factor: 2.537

3.  Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.

Authors:  Elizabeth Ormondroyd; Louise Donnelly; Clare Moynihan; Cornelie Savona; Elizabeth Bancroft; D Gareth Evans; Rosalind Eeles; Stuart Lavery; Maggie Watson
Journal:  Eur J Hum Genet       Date:  2011-08-03       Impact factor: 4.246

4.  A pilot study of BRCA mutation carriers' knowledge about the clinical impact of prophylactic-oophorectomy and views on fertility consultation: a single-center pilot study.

Authors:  J Kim; C Skrzynia; J E Mersereau
Journal:  J Genet Couns       Date:  2014-08-15       Impact factor: 2.537

5.  Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.

Authors:  Karen Hurley; Lisa R Rubin; Allison Werner-Lin; Michal Sagi; Yelena Kemel; Rikki Stern; Aliza Phillips; Ina Cholst; Noah Kauff; Kenneth Offit
Journal:  Cancer       Date:  2012-06-26       Impact factor: 6.860

6.  "It was an Emotional Baby": Previvors' Family Planning Decision-Making Styles about Hereditary Breast and Ovarian Cancer Risk.

Authors:  Marleah Dean; Emily A Rauscher
Journal:  J Genet Couns       Date:  2017-01-30       Impact factor: 2.537

7.  Much more than a gene: hereditary breast and ovarian cancer, reproductive choices and family life.

Authors:  Catherine Dekeuwer; Simone Bateman
Journal:  Med Health Care Philos       Date:  2013-05

8.  Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes.

Authors:  Thereasa A Rich; Mei Liu; Carol J Etzel; Sarah A Bannon; Maureen E Mork; Kaylene Ready; Devki S Saraiya; Elizabeth G Grubbs; Nancy D Perrier; Karen H Lu; Banu K Arun; Terri L Woodard; Leslie R Schover; Jennifer K Litton
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

9.  Impact of BRCA1/2 mutation on young women's 5-year parenthood rates: a prospective comparative study (GENEPSO-PS cohort).

Authors:  Julien Mancini; Emmanuelle Mouret-Fourme; Catherine Noguès; Claire Julian-Reynier
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

10.  Exploration of Male Attitudes on Partnerships and Sexuality with Female BRCA1/2 Mutation Carriers.

Authors:  Caitlin Mauer; Sara Spencer; Jeffery Dungan; Karen Hurley
Journal:  J Genet Couns       Date:  2015-08-08       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.